Tag: Multiple Sclerosis

Presence of three or more comorbidities, two or more cardiometabolic comorbidities, one psychiatric disorder linked to evidence of disease activity

Lower rate of amyloid-β plasma biomarker positivity seen in multiple sclerosis patients compared with non-MS controls

For patients with high MS activity, small increase in relapse risk seen after booster dose, especially for those not treated

Ofatumumab is more effective than teriflunomide for relapsing multiple sclerosis across subgroups

In Norwegian population, associations observed between maternal smoking, maternal smoking during pregnancy and MS risk

More improvement in timed 25-foot walk, six-minute walk test seen among those requiring assistance for ambulation

No association seen for mAb during breastfeeding with infant hospitalization, systemic antibiotic use, developmental delay

Generally favorable effect seen in terms of number of new gadolinium-enhancing T1-weighted lesions at week 12

White mothers more often employed and privately insured; birthweight lower for babies born to underrepresented women

Depression, sexual dysfunction, constipation, cystitis, UTI of unspecified site associated with MS diagnosis